Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
TUESDAY, May 21, 2024-- Dupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a study published online May 20 in the New England Journal of Medicine...